ProfMarian Brennan
Associate Professor
Graduate Entry Medicine
Orcid identifier0000-0003-2368-5383 (opens in a new tab)
- Associate ProfessorGraduate Entry Medicine
- 01 402 2789 (Work)
- RCSI, School of Pharmacy and Biomedical Sciences, 123 St Stephens Green, Dublin 2
RESEARCH OVERVIEW
The primary focus of my research is on host-pathogen interactions with a view to preventing these interactions. My research interests include Staphylococcal infections, malaria and platelet biology. My group uses 3D computational methods to design inhibitors for infectious diseases, validating these in the laboratory. I also have a specific interest in re-purposing of currently approved drugs. We are currently working on COVID-19 to identify associations between medication use and COVID-19 outcomes in the Drugs4COVID project. (www.youtube.com/watch?v=1wSiWgs2H5o&t=8s).
GRANTS
- FUNDED PROJECTStudent Selected Projects (SSP) 2027RCSI1 Oct 2026 - 30 Sep 2027
- FUNDED PROJECTThe development of novel diagnostic and therapeutic approaches for patients with heart failure with preserved ejection fraction (HFpEF)Research Ireland1 Sep 2026 - 31 Aug 2030
- FUNDED PROJECTThe development of novel diagnostic and therapeutic approaches for patients with heart failure with preserved ejection fraction (HFpEF)RCSI1 Sep 2026 - 31 Aug 2030
- FUNDED PROJECTBScATT 2026 PlacementsRCSI29 Jun 2026 - 31 Dec 2026
- FUNDED PROJECTStudent Selected Projects (SSP) 2026RCSI9 Feb 2026 - 21 Dec 2026
- FUNDED PROJECTUndergraduate Research FundingRCSI3 Sep 2025 - 2 Sep 2030
- FUNDED PROJECTNovel Therapeutics Targeting the FcgRIIa receptorIndustry - Cash20 May 2024 - 31 Dec 2026
- FUNDED PROJECTNovel Therapeutics Targeting the FcgRIIa receptorEnterprise Ireland20 May 2024 - 31 Dec 2026
- FUNDED PROJECTStudent Selected Projects (SSP) 2024RCSI29 Apr 2024 - 28 Apr 2025
- GRANTExploring attitudes towards interprofessional teamsIrish Network of Healthcare Educators15 Jan 2024 - 22 Mar 2024People funded by this grant:
- Brennan M
- FUNDED PROJECTBiomarker Criteria To Identify Patients With The Potential For The Greatest Benefit From GLP-1 Receptor Agonist TherapyRCSI11 Jul 2022 - 31 Oct 2024
- FUNDED PROJECTSSC Research Programme 2020RCSI1 Jan 2020 - 31 Mar 2021
- GRANTLead optimisation of Fc gamma RIIa antagonistsScience Foundation Ireland1 Feb 2018 - 31 Jan 2019
- GRANTDiscovery of small molecule inhibitors of the Fc gamma RIIaIndustry funding1 Jul 2016 - 31 Dec 2018
- FUNDED PROJECTThe development of novel Staphylococcus aureus inhibitors for the treatment of sepsis.Embassy (Kuwait)1 May 2016 - 31 Jul 2022
- GRANTRationally designed inhibitors of Staphylococcus aureus ColonizationScience Foundation Ireland1 Feb 2016 - 31 Jan 2017
- FUNDED PROJECTThe development of anti-Staphylococcal compounds for the treatment of Methicillin Resistant Staphylococcus aureus (MRSA) nasal colonization.Embassy (Saudi Arabia)1 Feb 2015 - 1 Feb 2016
- FUNDED PROJECTThe development of novel antagonists for the treatment of cardiovascular disease.Embassy (Kuwait)25 Sep 2014 - 7 Nov 2015
- FUNDED PROJECTTIL3A-100 as a novel therapeutic in SLEEnterprise Ireland1 Sep 2014 - 30 Apr 2016
- FUNDED PROJECTThe development of Pathogen-Specific Tags for the Activation of Phagocytosis.Enterprise Ireland1 Jul 2009 - 30 Jun 2010People funded by this grant:
- Timothy F
- GRANTStrategic Development Initiative - Chemoinformatics & Drug DiscoveryRCSI1 Jan 2009 - 15 Jul 2010
- GRANTDevelopment of small molecule Fc gamma RIIa antagonists as novel anti-platelet agents.Science Foundation Ireland1 Sep 2007People funded by this grant:
- Brennan M
- GRANTDevelopment of small molecule Fc gamma RIIa antagonists as novel anti-platelet agents.Science Foundation Ireland1 Sep 2007 - 1 Sep 2010